OAM
VNDA icon

Oxford Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Oxford Asset Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-129,045
Closed -$2.12M – 1280
2019
Q4 		$2.12M Buy
129,045
+36,850
+40% +$557K 0.06% 390
2019
Q3 		$1.22M Buy
92,195
+66,489
+259% +$927K 0.03% 825
2019
Q2 		$362K Buy
+25,706
New +$409K 0.01% 1397
2019
Q1 		– Sell
-55,298
Closed -$1.45M – 2005
2018
Q4 		$1.45M Sell
55,298
-55,064
-50% -$1.29M 0.04% 664
2018
Q3 		$2.52M Buy
110,362
+1,622
+1% +$33.1K 0.05% 534
2018
Q2 		$2.07M Sell
108,740
-11,684
-10% -$195K 0.04% 648
2018
Q1 		$2.03M Buy
120,424
+96,909
+412% +$1.62M 0.04% 567
2017
Q4 		$358K Sell
23,515
-152,650
-87% -$2.27M 0.01% 1291
2017
Q3 		$3.18M Sell
176,165
-48,116
-21% -$805K 0.06% 380
2017
Q2 		$3.66M Buy
224,281
+24,679
+12% +$356K 0.07% 295
2017
Q1 		$2.79M Sell
199,602
-557,905
-74% -$7.95M 0.07% 311
2016
Q4 		$12.1M Sell
757,507
-247,823
-25% -$3.98M 0.43% 37
2016
Q3 		$16.7M Buy
+1,005,330
New +$13.5M 0.52% 34
2016
Q2 		– Sell
-69,999
Closed -$585K – 884
2016
Q1 		$585K Buy
+69,999
New +$575K 0.02% 589
2015
Q4 		– Sell
-157,841
Closed -$1.78M – 952
2015
Q3 		$1.78M Buy
+157,841
New +$1.93M 0.06% 306
2015
Q2 		– Sell
-86,041
Closed -$800K – 746
2015
Q1 		$800K Sell
86,041
-254,246
-75% -$2.87M 0.02% 493
2014
Q4 		$4.95M Buy
340,287
+292,681
+615% +$3.46M 0.11% 204
2014
Q3 		$500K Buy
+47,606
New +$624K 0.01% 551
2014
Q2 		– Sell
-180,017
Closed -$2.92M – 783
2014
Q1 		$2.92M Buy
+180,017
New +$2.56M 0.09% 296
2013
Q4 		– Sell
-220,537
Closed -$2.42M – 794
2013
Q3 		$2.42M Buy
+220,537
New +$2.36M 0.05% 404

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Oxford Asset Management's VNDA Position: Q1 2020 in Review

Oxford Asset Management sold out of Vanda Pharmaceuticals (VNDA) in Q1 2020, closing a stake of 129,045 shares — an estimated $2.12M sold.

Oxford Asset Management first reported a position in VNDA in Q3 2013 and held it in 20 quarters. The position peaked at $16.7M in Q3 2016. 159 funds tracked by Wall St. Rank hold VNDA as of Q1 2020.

  • Oxford Asset Management reported no remaining Vanda Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Oxford Asset Management sold 129,045 Vanda Pharmaceuticals shares in Q1 2020, an estimated $2.12M.
  • Oxford Asset Management first reported a position in Vanda Pharmaceuticals in Q3 2013 and held it in 20 quarters.
  • Oxford Asset Management's Vanda Pharmaceuticals position peaked at $16.7M in Q3 2016.
  • 159 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.